In the context of OXA-induced colitis, KGM administration resulted in a marked reduction in the levels of critical inflammatory cytokines, specifically interleukin-4 (IL-4) and interleukin-13 (IL-13) (Onitake et al., 2015). Here, IL13 is linked to colitis.